妊娠期SARS-CoV-2感染患者的严重孕产妇发病率
这项多中心回顾性队列研究纳入2020年3月1日至2021年3月1日在纽约某医疗系统分娩且完成SARS-CoV-2检测的22483例孕妇,其中1653例(7.4%)阳性。阳性组严重孕产妇发病率9.3%高于阴性组6.5%(调整比值比1.52,95%置信区间1.21-1.88),严重产科出血、肺部疾病和重症监护室入住风险亦升高。
要点
- 妊娠期SARS-CoV-2感染与严重孕产妇发病率升高相关(9.3% vs 6.5%,调整比值比1.52)。
- 阳性组严重产科出血、肺部疾病和重症监护室入住风险均高于阴性组。
- 感染时机(分娩时活动性或已消退)与严重产科出血及高血压相关或神经系统疾病风险无关。
核心结论
- 妊娠期SARS-CoV-2感染与严重孕产妇发病率、严重产科出血、肺部疾病和重症监护室入住风险升高相关。
- 这些数据强调产科单元需做好照护SARS-CoV-2感染患者的准备,持续公共卫生努力以最小化感染风险,并支持将该特定人群纳入研究性治疗和疫苗试验。
研究设计与样本
- 多中心回顾性队列研究,纳入2020年3月1日至2021年3月1日在纽约某医疗系统分娩且完成SARS-CoV-2检测的所有孕妇,排除检测结果缺失者。
- 共纳入22483例患者,其中1653例(7.4%)SARS-CoV-2检测阳性。
- 主要结局为严重孕产妇发病率,源自美国妇产科医师学会和母胎医学学会的示例诊断与并发症列表,比较阳性组与阴性组。
- 采用多变量逻辑回归调整母亲人口学特征、社区社会经济状况、医院位置和妊娠相关并发症等潜在混杂因素。
- 亚组分析比较分娩住院时SARS-CoV-2阳性(活动性感染)与妊娠期阳性但分娩时阴性(已消退感染)者的严重产科出血及高血压相关或神经系统疾病风险。
主要发现
- SARS-CoV-2感染组严重孕产妇发病率9.3% vs 无感染组6.5%(调整比值比1.52;95%置信区间1.21-1.88)。
- SARS-CoV-2感染组严重产科出血1.1% vs 无感染组0.5%(调整比值比1.78;95%置信区间1.04-2.88)。
- SARS-CoV-2感染组肺部疾病2.0% vs 无感染组0.5%(调整比值比3.90;95%置信区间2.52-5.89)。
- SARS-CoV-2感染组重症监护室入住1.8% vs 无感染组0.5%(调整比值比3.29;95%置信区间2.09-5.04)。
- 两组高血压相关或神经系统疾病风险相似;感染时机(活动性或已消退)与严重产科出血或高血压相关或神经系统疾病风险无关。
临床怎么用
- 原文结论强调产科单元需做好照护SARS-CoV-2感染患者的准备。
- 原文结论支持持续公共卫生努力以最小化感染风险。
- 原文结论支持将该特定人群纳入研究性治疗和疫苗试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although the increased risk for severe illness and adverse pregnancy outcomes associated with SARS-CoV-2 infection during pregnancy is well described, the association of infection with severe maternal morbidity has not been well characterized. OBJECTIVE: This study aimed to evaluate the risk for severe maternal morbidity associated with SARS-CoV-2 infection during pregnancy. STUDY DESIGN: This was a multicenter retrospective cohort study of all pregnant patients who had a SARS-CoV-2 test done and who delivered in a New York health system between March 1, 2020 and March 1, 2021. Patients with missing test results were excluded. The primary outcome of severe maternal morbidity, derived from the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine example list of diagnoses and complications, was compared between the following 2 groups: patients who tested positive for SARS-CoV-2 during pregnancy and patients who tested negative. Secondary outcomes included subgroups of severe maternal morbidity. Multivariable logistic regression was used to adjust for potential confounders such as maternal demographics, neighborhood socioeconomic status, hospital location, and pregnancy-related complications. A subanalysis was performed to determine if the risk for severe obstetrical hemorrhage and hypertension-associated or neurologic morbidity differed based on the timing of SARS-CoV-2 infection between those who tested positive for SARS-CoV-2 at their delivery hospitalization (ie, active infection) and those who tested positive during pregnancy but negative at their delivery hospitalization (ie, resolved infection). RESULTS: Of the 22,483 patients included, 1653 (7.4%) tested positive for SARS-CoV-2 infection. Patients with SARS-CoV-2 infection were more commonly Black, multiracial, Hispanic, non-English speaking, used Medicaid insurance, were multiparous, and from neighborhoods with a lower socioeconomic status. Patients with SARS-CoV-2 infection were at an increased risk for severe maternal morbidity when compared with those without infection (9.3 vs 6.5%; adjusted odds ratio, 1.52; 95% confidence interval, 1.21-1.88). Patients with SARS-CoV-2 infection were also at an increased risk for severe obstetrical hemorrhage (1.1% vs 0.5%; adjusted odds ratio, 1.78; 95% confidence interval, 1.04-2.88), pulmonary morbidity (2.0% vs 0.5%; adjusted odds ratio, 3.90; 95% confidence interval, 2.52-5.89), and intensive care unit admission (1.8% vs 0.5%; adjusted odds ratio, 3.29; 95% confidence interval, 2.09-5.04) when compared with those without infection. The risk for hypertension-associated or neurologic morbidity was similar between the 2 groups. The timing of SARS-CoV-2 infection (whether active or resolved at time of delivery) was not associated with the risk for severe obstetrical hemorrhage or hypertension-associated or neurologic morbidity when compared with those without infection. CONCLUSION: SARS-CoV-2 infection during pregnancy was associated with an increased risk for severe maternal morbidity, severe obstetrical hemorrhage, pulmonary morbidity, and intensive care unit admission. These data highlight the need for obstetrical unit preparedness in caring for patients with SARS-CoV-2 infection, continued public health efforts aimed at minimizing the risk for infection, and support in including this select population in investigational therapy and vaccine trials.
引用
- Gulersen M, Rochelson B, Shan W, et al. Severe maternal morbidity in pregnant patients with SARS-CoV-2 infection. Am J Obstet Gynecol MFM. 2022. PMID: 35398348. doi:10.1016/j.ajogmf.2022.100636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。